Jacobs Levy Equity Management
RBOT

Jacobs Levy Equity Management’s Vicarious Surgical RBOT Stock Holding History

Jacobs Levy Equity Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,673
Closed -$60.4K – 1029
2024
Q1 		$60.4K Sell
6,673
-28,887
-81% -$345K ﹤0.01% 922
2023
Q4 		$391K Buy
35,560
+11,883
+50% +$132K ﹤0.01% 860
2023
Q3 		$420K Buy
+23,677
New +$862K ﹤0.01% 834

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management's RBOT Position: Q2 2024 in Review

Jacobs Levy Equity Management sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 6,673 shares — an estimated $60.4K sold.

Jacobs Levy Equity Management first reported a position in RBOT in Q3 2023 and held it in 3 quarters. The position peaked at $420K in Q3 2023. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Jacobs Levy Equity Management reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 6,673 Vicarious Surgical shares in Q2 2024, an estimated $60.4K.
  • Jacobs Levy Equity Management first reported a position in Vicarious Surgical in Q3 2023 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Vicarious Surgical position peaked at $420K in Q3 2023.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2024, filed 14 Aug 2024.